1
|
Koffi Teki DSE, Coulibaly B, Bil A, Vallin A, Lesur D, Fanté B, Chagnault V, Kovensky J. Synthesis of novel S- and O-disaccharide analogs of heparan sulfate for heparanase inhibition. Org Biomol Chem 2022; 20:3528-3534. [PMID: 35388870 DOI: 10.1039/d2ob00250g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Heparan sulfate (HS), a glycosaminoglycan related to heparin, is a linear polysaccharide, consisting of repeating disaccharide units. This compound is involved in multiple biological processes such as inflammation, coagulation, angiogenesis and viral infections. Our work focuses on the synthesis of simple HS analogs for the study of structure-activity relationships, with the aim of modulating these biological activities. Thioglycoside analogs, in which the interglycosidic oxygen is replaced by a sulfur atom, are very interesting compounds in terms of therapeutic applications. Indeed, the thioglycosidic bond leads to an improvement of their stability and can allow the inhibition of enzymes involved in physiological and pathological processes. In our previous work, we developed a synthetic sequence which led to a non-sulfated thiodisaccharide analog of HS. In this paper, we report our results of the development of a new synthetic method allowing access to the novel sulfated S-disaccharide, as well as to their oxygenated analogues (O-disaccharide and sulfated O-disaccharide). These 4 compounds were also tested for the inhibition of heparanase, an enzyme involved in biological processes like tumor growth and inflammation. The obtained IC50 values in the micromolar range showed the impact of the interglycosidic sulfur atom and the 6-sulfate group.
Collapse
Affiliation(s)
- D S-E Koffi Teki
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| | - B Coulibaly
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France. .,Laboratoire de Constitution et Réaction de la Matière (LCRM), Université Félix Houphouët-Boigny (UFHB) de Cocody - Côte d'Ivoire, 22 BP 582 Abidjan 22, Côte d'Ivoire
| | - A Bil
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| | - A Vallin
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| | - D Lesur
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| | - B Fanté
- Laboratoire de Constitution et Réaction de la Matière (LCRM), Université Félix Houphouët-Boigny (UFHB) de Cocody - Côte d'Ivoire, 22 BP 582 Abidjan 22, Côte d'Ivoire
| | - V Chagnault
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| | - J Kovensky
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A), UMR 7378 CNRS, Université de Picardie Jules Verne, 33 rue Saint Leu, F-80039 Amiens Cedex, France.
| |
Collapse
|
2
|
Hao S, Lin S, Wang X, An R, Guo M, Wang Y, Cheng X, Xu H, Yang X, Hou Z, Guo C. Sequential one-pot synthesis of (1→6) amide-linked oligosaccharide mimetics under mild conditions. J Carbohydr Chem 2020. [DOI: 10.1080/07328303.2020.1798456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Shuang Hao
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Shuai Lin
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Xin Wang
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Ran An
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Mengbi Guo
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Yuanxin Wang
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Xue Cheng
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Hang Xu
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Xiaoguang Yang
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Zhuang Hou
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| | - Chun Guo
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China
| |
Collapse
|